Countries using and planning to introduce IPV September 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV ID: 139627
Download Presentation The PPT/PDF document "Countries using and planning to introduc..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Countries using and planning to introduce IPVSlide2
Countries using and planning to introduce IPVSeptember 2015 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact
polio2@who.int
with any questions or updates on this data.
Definitions
Formal decision
to introduce:
The country has documentation of its decision
to introduce
IPV which has
been verified by the relevant WHO Regional
Office, or for GAVI eligible countries, a complete application for IPV has been submitted to the GAVI Secretariat.
Intent
to introduce:
The country has informally indicated that it plans to introduce IPV, e.g. planning an application
to
GAVI, or by requesting technical
assistance to
develop an
IPV introduction
plan.
Tracking
these
decisions and informal
intents provide an indication of the global trend towards meeting
the targets of the
Polio Eradication and Endgame Strategic Plan
.Slide3
Countries using IPV vaccine to dateand formal decision/intent to introduce
Data source: WHO/IVB Database, as of 03 September 2015Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 September 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(104 countries or 54%)
Formal commitment to introduce in 2015
(59 countries or 30%)
Introduction delayed to 2016 due to global IPV vaccine shortage
(31 countries or 16%)
Not available
Not applicable
Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea & the former Y
ugoslav
Rep
of Macedonia (
August
2015); Guyana & Jamaica (
September
2015)
*NB
. From 3 August 2015, all countries were categorized as either having introduced IPV or formally committed to introducing according to the Polio Endgame timelines. Slide4
Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status
Data source: WHO/IVB Database, as of 03 September 2015Map production Immunization Vaccines and Biologicals (IVB),World Health Organization
Date of slide: 3 September 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(104 countries or 54%)
Gavi
countries with formal commitment to introduce in 2015-16
(51 countries or 26%)
Non
Gavi
countries with formal commitment to introduce in 2015-16
(39 countries or 20%)
Not available
Not applicable
Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea & the former Y
ugoslav
Rep
of Macedonia (
August
2015); Guyana & Jamaica (
September
2015)Slide5
90 countries introducing IPV between 03 September 2015 and June 2016
Tier 1 countries are countries with cVDPV2 transmission or
cVDPV2
reported since 2000 & WPV endemic
countries
Tier
2 countries
are countries
with
cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3
years as per WUENIC Source: WHO/UNICEF database as at
03 September 2015
Argentina
–– Mauritius - Namibia and Yemen are
introducing in 2015 but no month of introduction available
. Slide6
Tier 1 and 2 Countries using IPV vaccine to dateand formal decision to introduce
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countriesTier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries
with DTP3 coverage <80% in the past 3 years as per WUENIC
Data source: WHO/IVB Database, as of 03 September 2015,
based on 35 tier 1 & 2 countries
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 September 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduction to date
(24 countries or 69%)
Formal commitment to introduce in 2015-16
(11 countries or 31%)
Not applicable or not Tier 1 or 2 countries
(159 countries or 82%)
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015)Slide7
Middle Income Countries using IPV vaccine to dateand formal/intent decision to introduce
Data source: WHO/IVB Database, as of 03 September 2015 based on 101middle income countries (MIC) as per last World Bank classification
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 September 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(45 countries or 45%)
Formal commitment to introduce in 2015
(37 countries or 37%)
Formal commitment to introduce in 2016
(18 countries or 18%)
Not available / Not applicable / Non MIC countries
Since January 2013, the following MIC have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015);
M
aldives (March 2015) and Cote d'Ivoire, Kiribati,
Morocco,St
Vincent and the Grenadines & Sudan (June 2015);
Bhutan
, Cameroon,
Pakistan & Sri Lanka (July 2015
); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Guyana & Jamaica (September 2015)
Slide8
IPV introduction status and planned introduction
by quarter by the end of 2015 status reportData source: WHO/IVB Database, as of 03 September 2015Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 September 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(104 countries or 54%)
Introduction planned in Q3 2015
(12 countries or 6%)
Introduction planned in Q4 2015
(45 countries or 23%)
Introduction delayed to 2016 due to global IPV vaccine shortage or planned in 2015 but month of introduction not known
(33 countries or 17%)
Not available
Not applicable
Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea & the former Y
ugoslav
Rep
of Macedonia (
August
2015); Guyana & Jamaica (
September
2015)